Clopidogrel is a commonly used drug for ischemic stroke and is an inactive precursor drug that binds ADP receptors on the platelet membrane surface, preventing the glycoprotein GPIIb/IIIa receptors from binding to fibrinogen and antagonizing platelet aggregation. This evidence concerns the gene P2RY1 and ischemic stroke.